JPMorgan maintains Babcock stock rating ahead of results

JPMorgan analysts have reiterated an Overweight rating on Babcock International (LON:BAB) with a price target of £12.80, placing the stock on a Positive Catalyst Watch ahead of its March 2025 year-end results on June 25. The positive outlook is driven by expectations of new medium-term financial guidance and Babcock's position as a key beneficiary of the UK Strategic Defence Review, with EPS estimates exceeding Vuma consensus by 7%, 6%, and 5% for fiscal years 2025-2027 respectively, suggesting a 25% upside potential.

Analysis

JPMorgan analysts have reaffirmed their Overweight rating on Babcock International Group (LON:BAB) Plc, maintaining a £12.80 price target, and have designated the stock as a "Positive Catalyst Watch" leading up to its year-end results for March 2025, which are scheduled for June 25. This optimistic stance is underpinned by two primary factors: the anticipation of new medium-term financial guidance from Babcock and its positioning as a key beneficiary of the recently announced UK Strategic Defence Review. The maintained price target implies a potential upside of approximately 25% over the next 18 months, a projection supported by JPMorgan's earnings per share estimates for fiscal years ending March 2025 through 2027, which stand 7%, 6%, and 5% above Vuma consensus, respectively. Furthermore, Babcock is highlighted for its relative valuation, being noted as one of the most affordable European defense stocks within JPMorgan's coverage, which could enhance its appeal to investors. Analysts expect Babcock to elaborate on the opportunities arising from the Strategic Defence Review during its upcoming results presentation.

Key Decisions for Investors

• Investors may consider Babcock International (LON:BAB) favorably, given the reiterated Overweight rating, a potential 25% upside indicated by JPMorgan's price target, and its strategic alignment with UK defense sector growth.
• The upcoming year-end results announcement on June 25 should be closely monitored, as it is flagged as a positive catalyst event where new medium-term financial guidance and details on benefits from the UK Strategic Defence Review are anticipated.
• Babcock's valuation, described as one of the most affordable among European defense peers, combined with JPMorgan's above-consensus earnings per share estimates for FY25-27, presents a potentially attractive entry point for investors seeking exposure to the defense industry.